Does abdominal obesity influence immunological response to SARS-CoV-2 infection?

Sanchis-Gomar, Fabian; Lavie, Carl J; Neeland, Ian J; Lippi, Giuseppe

Sanchis-Gomar, Fabian; Lavie, Carl J; Neeland, Ian J; Lippi, Giuseppe.

Sanchis-Gomar F; Department of Physiology, Faculty of Medicine, University of Valencia and Incliva Biomedical Research Institute, Valencia, Spain.
Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, USA.
Neeland IJ; UH Center for Cardiovascular Prevention and Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Lippi G; Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

Expert Rev Endocrinol Metab ; 16(6): 271-272, 2021 11.

Article in English | MEDLINE | ID: covidwho-1409073

Subject(s)

COVID-19; Humans; Obesity; Obesity, Abdominal; SARS-CoV-2

Keywords

COVID-19; Obesity; immune function; prognosis; severity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Expert Rev Endocrinol Metab Year: 2021 Document Type: Article Affiliation country: 17446651.2021.1979392

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google